Arax Advisory Partners’s MindMed MNMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.25K | Buy |
501
+237
| +90% | +$1.54K | ﹤0.01% | 2390 |
|
2025
Q1 | $1.55K | Sell |
264
-12
| -4% | -$70 | ﹤0.01% | 2157 |
|
2024
Q4 | $1.92K | Buy |
276
+248
| +886% | +$1.73K | ﹤0.01% | 2021 |
|
2024
Q3 | $160 | Hold |
28
| – | – | ﹤0.01% | 2530 |
|
2024
Q2 | $202 | Hold |
28
| – | – | ﹤0.01% | 2438 |
|
2024
Q1 | $264 | Hold |
28
| – | – | ﹤0.01% | 1267 |
|
2023
Q4 | $103 | Hold |
28
| – | – | ﹤0.01% | 1310 |
|
2023
Q3 | $88 | Hold |
28
| – | – | ﹤0.01% | 1300 |
|
2023
Q2 | $100 | Hold |
28
| – | – | ﹤0.01% | 1250 |
|
2023
Q1 | $89 | Hold |
28
| – | – | ﹤0.01% | 1252 |
|
2022
Q4 | $62 | Buy |
+28
| New | +$62 | ﹤0.01% | 1257 |
|
2022
Q1 | – | Sell |
-29
| Closed | -$1K | – | 1186 |
|
2021
Q4 | $1K | Buy |
29
+3
| +12% | +$103 | ﹤0.01% | 1041 |
|
2021
Q3 | $1K | Hold |
26
| – | – | ﹤0.01% | 921 |
|
2021
Q2 | $1K | Buy |
+26
| New | +$1K | ﹤0.01% | 886 |
|